
Applied Nanodetectors Ltd, founded in 2004, is a leading developer and supplier of nanosensor-based solutions for environmental, healthcare, and medical markets worldwide. Their flagship product, Exhale-Dx™, is a non-invasive point-of-care breath diagnostic platform that uses biomarker detection, lung function measurements, and AI algorithms to predict asthma attacks up to 3 days in advance with 93% accuracy. The platform includes a device, disease management software, and a cloud-based patient management system that provides healthcare professionals with actionable insights and early alerts for patient deterioration. The company focuses on improving health outcomes through innovative breath analysis technology, edge AI, and secure data transfer, targeting respiratory diseases such as asthma. Applied Nanodetectors has established partnerships with leading hospitals like Great Ormond Street Hospital and Rady’s Children Hospital, and has received multiple innovation awards and grants. Their business model is primarily SaaS and subscription-based, delivering personalized self-management tools for patients and healthcare providers globally.

Applied Nanodetectors Ltd, founded in 2004, is a leading developer and supplier of nanosensor-based solutions for environmental, healthcare, and medical markets worldwide. Their flagship product, Exhale-Dx™, is a non-invasive point-of-care breath diagnostic platform that uses biomarker detection, lung function measurements, and AI algorithms to predict asthma attacks up to 3 days in advance with 93% accuracy. The platform includes a device, disease management software, and a cloud-based patient management system that provides healthcare professionals with actionable insights and early alerts for patient deterioration. The company focuses on improving health outcomes through innovative breath analysis technology, edge AI, and secure data transfer, targeting respiratory diseases such as asthma. Applied Nanodetectors has established partnerships with leading hospitals like Great Ormond Street Hospital and Rady’s Children Hospital, and has received multiple innovation awards and grants. Their business model is primarily SaaS and subscription-based, delivering personalized self-management tools for patients and healthcare providers globally.
Founded: 2004
Headquarters: Enfield, United Kingdom
Core product: Exhale-Dx breath diagnostic platform
Technology focus: Nanosensor arrays, edge AI for breath and air-quality sensing
Recent funding: SBRI Healthcare grant (Nov 2016)
Respiratory disease diagnostics and indoor air quality monitoring
2004
Biotechnology
Grant-type funding announced Nov 1, 2016 (listed as lead)
“SBRI Healthcare (grant funding / Innovate UK SBRI support)”